VC Deals (16 deals, $330M invested) Zai Labs, a Shanghai-based drug developer whose lead candidate is focused on treating liver cancer, has raised more than $100 million in Series B funding. [...]
VC Deals (7 deals, $120M) ObsEva, a Swiss developer of drugs that address “serious conditions compromising pregnancy from conception to birth,” has raised around $60 million in Series B funding. [...]
Software eats medicine: Andreessen Horowitz this morning will announce that it has raised $200 million for a new fund “focused on the intersection of computer sciences and life sciences. It will [...]
VC Deals (12 deals, $280M) Personal Genome Diagnostics, a Baltimore-based provider of advanced cancer genome testing products and services, raised $21.4 million in a Series A funding round led by [...]
VC Deals (11 deals, $340M) Verisma Systems, a Pueblo, Colo.-based provider of “release of information” services to healthcare organizations, has raised $14.55 million in growth equity funding [...]
VC Deals (12 deals, $109M raised) TAI Diagnostics Inc., a Wauwatosa, Wis.-based developer of diagnostic tests for monitoring the health of transplanted organs, has raised $8.2 million in Series A [...]
VC Deals (14 deals, $480M) HealthiPASS, a Chicago-based patient check-in and payments company, has raised an undisclosed amount of Series A funding. OCA Ventures led the round, and was joined by [...]
VC Deals Doctolib, a French platform for booking doctor appointments, has raised €18 million in Series B funding led by Accel Partners FabFitFun, a Los Angeles-based “lifestyle brand inspiring [...]
Venture funding of healthtech companies in 2015 to date is ahead of 2014 YoY: funding to date exceeds $3.3B Key Trends Steady increase in mid stage (Series B and C) deals. Early stage deals hold [...]
http://www.forbes.com/sites/unitystoakes/2015/08/01/the-leapfrog-opportunity-in-the-worlds-underserved-health-care-markets/?utm_source=StartUp Health [...]
- 1
- 2